ClinicaliQ Trial Snapshot
- Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT04513054.
- What is being tested: The study investigates whether genetic factors predispose certain individuals to developing takotsubo cardiomyopathy (stress-induced cardiomyopathy), rather than this condition occurring purely due to environmental stressors.
- Patient eligibility overview: The trial includes patients who have experienced acute stress-induced cardiomyopathy presenting with acute coronary syndrome-like symptoms, alongside control participants without the condition, to enable genetic comparison between affected and unaffected populations.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences. In the current study the investigators wish to establish whether there is a genetic predisposition making certain people more susceptible to this condition. This could also have implications for their families.
Eligibility Snapshot
- : * All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date. * Familial cases elsewhere in the world who would be willing to participate.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.